Stay updated on BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.

Latest updates to the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a backend/template release. No study data or visible content on the page was altered.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now displays a newer ClinicalTrials.gov site revision/version identifier (“Revision: v3.5.3”) instead of the previous one (“v3.5.0”). This reflects a system/UI update rather than a change to the study details.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check95 days agoChange DetectedThe page shows a new revision label, 'v3.4.2', replacing 'v3.4.1'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check103 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a minor metadata page change and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.